Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,977,112
+$5,677,832 QoQ
Shares Held
416,814
+2356.8% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $270,576,893 across 25 Diagnostics & Research names. SHC ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
278,942 | $52,887,403 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
94,073 | $46,239,701 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
29,451 | $37,143,601 | |
| 4 | WAT |
Waters Corp /De/
|
90,769 | $27,031,008 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
44,565 | $21,399,667 | |
| 6 | DGX |
Quest Diagnostics Inc
|
93,277 | $18,280,426 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
32,128 | $18,052,401 | |
| 8 | LH |
Labcorp Holdings Inc.
|
34,784 | $9,280,719 |
All Filings in SHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,977,112 | 416,814 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $299,280 | 16,966 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,505,288 | 222,841 | Shares | Sole | 2025-11-19 | |
| 2024-09-30 | $4,770,505 | 285,659 | Shares | Sole | 2024-11-14 | |
| 2022-06-30 | $17,611 | 899 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $10,288 | 475 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||